Health · 5 views
High-Dose Vitamin D Fails to Improve Survival in Dialysis Patients
Health 
Story intelligence
Coverage Single outlet Single-outlet story
Views 5 Community interest
Brief read Under 1 min brief 31 words
Summary
(MedPage Today) -- DENVER -- Supplementation with high-dose cholecalciferol (vitamin D3) did not improve overall survival in patients receiving dialysis for end-stage kidney disease, according to findings from the SIMPLIFIED trial.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Are you dressed yet? How parents can build child‑friendly routines that kids can followContinue reading
- Tired, irritable and craving carbs? Why darker days affect our bodies and brainsContinue reading
- 'Magic Drug' Reduces Risk of Death by 44% in Lung Cancer TrialContinue reading
- Immunotherapy combo extends survival for patients with aggressive small cell lung cancer, based on trial resultsContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow